The ability of α-syn to bind with VMAT2 and VAMP2 is significantly impaired following MPP+ exposure, which is substantially restored by treatment with APROM2, confirming APROM2’s ability to reprogram the biological function of α-syn in MPP+-induced cell model of Parkinson’s disease (PD). The gene discussed is SLC18A2; the disease is Parkinson disease.